Facilitating Smoking Cessation With Reduced Nicotine Cigarettes

PHASE2CompletedINTERVENTIONAL
Enrollment

163

Participants

Timeline

Start Date

September 7, 2017

Primary Completion Date

August 24, 2021

Study Completion Date

August 24, 2021

Conditions
Smoking Cessation
Interventions
DRUG

Very Low Nicotine Content (VLNC) Cigarettes

"Eligible participants will receive a 1-week supply (based on typical # cigarettes/day x 1.5) of normal nicotine content (NNC) (.8 mg nicotine yield) study cigarettes to smoke exclusively during one baseline week.~Study 1: Participants (n=20) will then be randomly selected to receive either the lowest nicotine dose of VLNC cigarettes, or gradual decreasing nicotine VLNC cigarettes, ten participants per each group, over the next four weeks.~Study 2: Participants (n=208) will be randomly assigned to 1 of 4 Study 2 Reduction Arms, 52 participants per arm."

BEHAVIORAL

One on One Counseling

All participants will receive One on One Counseling.

Trial Locations (1)

33612

H. Lee Moffitt Cancer Center and Research Institute, Tampa

All Listed Sponsors
collaborator

James and Esther King Biomedical Research Program

OTHER

lead

H. Lee Moffitt Cancer Center and Research Institute

OTHER

NCT02796391 - Facilitating Smoking Cessation With Reduced Nicotine Cigarettes | Biotech Hunter | Biotech Hunter